Success Stories

FORT MILL, S.C., June 29, 2021 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, today announced a strategic alliance with Halomine, Inc.™ and a global exclusive license agreement for their patented HaloFilmTM technology for institutional and food and beverage markets.

Halomine, based in the United States, is developing a suite of game-changing, novel, long-acting, anti-microbial products with technologies licensed from Cornell University and Auburn University. The revolutionary and patented HaloFilm technology offers residual disinfection efficacy for up to 30 days when used in combination with a weekly application of a chlorine-based disinfectant, without the requirements for a major change in cleaning routines. This enables residual disinfection claims against bacteria and viruses on a wide range of surfaces. While commonly used chlorine-based disinfectants are highly effective in killing bacteria and viruses on surfaces, they do not protect surfaces after the initial disinfection, leaving surfaces susceptible to nearly immediate recontamination.

“Our strategic alliance with Halomine and the addition of HaloFilm to our infection prevention portfolio is another example of our commitment to support our customers in the global fight against the spread of infectious diseases,” said Phil Wieland, Chief Executive Officer of Diversey Holdings, Ltd. “This reflects Diversey’s mission to protect and care for people and the environment. HaloFilm is a unique technology that will revolutionize cleaning routines across a wide range of market sectors and geographies and we are fortunate to be in a position to roll-out this technology with immediate effect.”

Ted Eveleth, Chief Executive Officer of Halomine on today's announcement said “We are proud that a global leader in professional cleaning and hygiene like Diversey will extend the reach of our technology across the globe, making a positive impact by breaking the chain of infection across multiple verticals and applications.”

About Halomine
Halomine Inc. is a Cornell University-based spin out company founded in 2018 to develop a suite of innovative, long lasting antimicrobial products based on the use of N-Halomine technology licensed from Cornell University and Auburn University. Our first product, HaloFilm™, a chlorine extender, provides long lasting protection against viruses, bacteria, and molds in hospitals, schools, offices, mass transit, food processing, and more; wherever pathogens spread and endanger human health.

For more information, visit

About Diversey
Diversey’s mission is to protect and care for people through leading hygiene, infection prevention, and cleaning solutions. We develop and deliver innovative products, services, and technologies that save lives and protect our environment. Over the course of 95 years, the Diversey brand has become synonymous with product quality, service, and innovation.

For more information, visit or follow us on LinkedIn, Facebook, or Twitter @diversey

Diversey Holdings, Ltd.
Media Contact:
Vani Chokra

Investor Contact:
Grant Graver

We recently spoke with Gilburt Chiang, who heads up Business Development for electric power solution provider Bigwood Systems (BSI) -- located on our Thornwood Drive -- some questions about operating within the Cornell Business and Technology Park.

Proximity to landlord/developer and venture investor, our location presents connections to business opportunities that you cannot find anywhere else.

I think it is the only location in the area that embodies a high quality technology looking industrial space, not repurposed old buildings, not a dense pack location, and not in a field, it is close to everything.  

I have built three buildings in the Park over twenty years as my businesses expanded and diversified, and will continue to do so in the future.

- Greg Galvin – Rheonix, President, Chief Executive Officer and Chairman of the Board of Directors

Jan Biotech, Inc. received the grant co-funded through the National Institute of Allergy and Infectious Disease and the National Institute of Mental Health, within the National Institutes of Health, said Janet Huie, chief scientific officer and co-founder of Jan Biotech, Inc. The business received the grant for its work in HIV research.

Read more in the Ithaca Journal

"Kionix developed two more highly profitable applications for its inertial sensors: enabling cell phones to switch from portrait to landscape mode and making possible motion- based computer gaming systems. When the technology was adopted by such major manufacturers as Samsung, Microsoft, and Nintendo, employment at Kionix grew to 250 people. "

- Cornell Enterprise Online, Winter 2016, Profile in Leadership: Greg Galvin, MS '82, PhD '84, MBA '93